The author is in the Laboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana 59840, USA.
New antibodies specific for the misfolded, and presumably pathogenic, form of the PrP protein have now made their long-awaited debut. These antibodies could provide tools for diagnostics, research and therapy (pages 893−899).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
